These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 32474036)

  • 1. Qualitative serology in patients recovered from SARS CoV 2 infection.
    Bettencourt P; Fernandes C; Gil A; Almeida A; Alvelos M
    J Infect; 2020 Aug; 81(2):e120-e121. PubMed ID: 32474036
    [No Abstract]   [Full Text] [Related]  

  • 2. Is SARS-CoV-2 Serology Relevant for Hemodialysis Patients With COVID-19?
    Dudreuilh C; Moutzouris DA
    Am J Kidney Dis; 2020 Oct; 76(4):598. PubMed ID: 32603711
    [No Abstract]   [Full Text] [Related]  

  • 3. Good IgA Bad IgG in SARS-CoV-2 Infection?
    Béné MC; de Carvalho Bittencourt M; Eveillard M; Le Bris Y
    Clin Infect Dis; 2020 Jul; 71(15):897-898. PubMed ID: 32280952
    [No Abstract]   [Full Text] [Related]  

  • 4. In Reply to 'Is SARS-CoV-2 Serology Relevant for Hemodialysis Patients With COVID-19?'.
    De Vriese AS; Reynders M
    Am J Kidney Dis; 2020 Oct; 76(4):598-599. PubMed ID: 32603712
    [No Abstract]   [Full Text] [Related]  

  • 5. Dynamics of anti-SARS-Cov-2 IgM and IgG antibodies among COVID-19 patients.
    Lee YL; Liao CH; Liu PY; Cheng CY; Chung MY; Liu CE; Chang SY; Hsueh PR
    J Infect; 2020 Aug; 81(2):e55-e58. PubMed ID: 32335168
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of Three Commercial Automated Assays for the Detection of Anti-SARS-CoV-2 Antibodies.
    Harb R; Remaley AT; Sacks DB
    Clin Chem; 2020 Oct; 66(10):1351-1353. PubMed ID: 32761081
    [No Abstract]   [Full Text] [Related]  

  • 7. Serological Assays for SARS-CoV-2 Infectious Disease: Benefits, Limitations and Perspectives.
    Infantino M; Damiani A; Gobbi FL; Grossi V; Lari B; Macchia D; Casprini P; Veneziani F; Villalta D; Bizzaro N; Cappelletti P; Fabris M; Quartuccio L; Benucci M; Manfredi M
    Isr Med Assoc J; 2020 Apr; 22(4):203-210. PubMed ID: 32286019
    [No Abstract]   [Full Text] [Related]  

  • 8. Mining the Antibody Repertoire for Solutions to SARS-CoV-2.
    Meng W; Rosenfeld AM; Luning Prak ET
    Cell Host Microbe; 2020 Oct; 28(4):499-501. PubMed ID: 33031765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Commentary on "A comparative overview of COVID-19, MERS and SARS: Review article" (International Journal of Surgery 2020; 81:1-8).
    Awais S; Shah SFH; Shah SGS
    Int J Surg; 2020 Nov; 83():28-29. PubMed ID: 32927142
    [No Abstract]   [Full Text] [Related]  

  • 10. SARS-CoV-2 infection complicated by inflammatory syndrome. Could high-dose human immunoglobulin for intravenous use (IVIG) be beneficial?
    Prete M; Favoino E; Catacchio G; Racanelli V; Perosa F
    Autoimmun Rev; 2020 Jul; 19(7):102559. PubMed ID: 32361195
    [No Abstract]   [Full Text] [Related]  

  • 11. Sex-biased Immune Responses Following SARS-CoV-2 Infection.
    Ursin RL; Shapiro JR; Klein SL
    Trends Microbiol; 2020 Dec; 28(12):952-954. PubMed ID: 33077340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of coronavirus disease-19 (COVID-19) based on SARS autopsy].
    Ding YQ; Bian XW
    Zhonghua Bing Li Xue Za Zhi; 2020 Apr; 49(4):291-293. PubMed ID: 32268662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative overview of COVID-19, MERS and SARS: Review article.
    Liu J; Xie W; Wang Y; Xiong Y; Chen S; Han J; Wu Q
    Int J Surg; 2020 Sep; 81():1-8. PubMed ID: 32730205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2.
    Du RH; Liang LR; Yang CQ; Wang W; Cao TZ; Li M; Guo GY; Du J; Zheng CL; Zhu Q; Hu M; Li XY; Peng P; Shi HZ
    Eur Respir J; 2020 Sep; 56(3):. PubMed ID: 32907886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2.
    Yang HJ; Zhang YM; Yang M; Huang X
    Eur Respir J; 2020 Sep; 56(3):. PubMed ID: 32747392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mortality from COVID-19: are we getting closer to the true value?
    Fonzo M; Bertoncello C; Baldo V
    Pathog Glob Health; 2020 Oct; 114(7):347-348. PubMed ID: 33012277
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of clinical characteristics of coronavirus disease (COVID-19) and severe acute respiratory syndrome (SARS) as experienced in Taiwan.
    Su YJ; Lai YC
    Travel Med Infect Dis; 2020; 36():101625. PubMed ID: 32184131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Low-Pathogenic Human Coronavirus-Specific Antibodies on SARS-CoV-2.
    Jiang S; Du L
    Trends Immunol; 2020 Oct; 41(10):853-854. PubMed ID: 32863133
    [No Abstract]   [Full Text] [Related]  

  • 19. Origin of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and COVID-19.
    Byard RW; Hunsaker J; Tsokos M
    Forensic Sci Med Pathol; 2020 Dec; 16(4):745. PubMed ID: 33104977
    [No Abstract]   [Full Text] [Related]  

  • 20. Coagulopathy and mesenteric ischaemia in severe SARS-CoV-2 infection.
    English W; Banerjee S
    ANZ J Surg; 2020 Sep; 90(9):1826. PubMed ID: 32621375
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.